Association between foveal microstructure and visual outcome in age-related macular degeneration

Retina

Volumn 31, Issue 8, 2011, Pages 1627-1636

  Shin, Hyun Jin ^a   Chung, Hyewon ^a   Kim, Hyung Chan ^a  

^a Konkuk University Hospital   (South Korea)

Author keywords

age related macular degeneration; integrity of photoreceptor layer; prognostic factors; visual outcome

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXUDATE; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PHOTORECEPTOR INNER SEGMENT; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; PROGNOSIS; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PHOTORECEPTOR CELLS, VERTEBRATE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 80052513801     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31820d3d01     Document Type: Article

References (32)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 1999;117:1329-1345.
2. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in agerelated macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-560.
3. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 2001;119:198-207. (Pubitemid 32147926)
4. Joeres S, Kaplowitz K, Brubaker JW, et al. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. Ophthalmology 2008;115:347-354.
5. Kaiser PK, Blodi BA, Shapiro H, et al. Angiographic and optical coherence tomographic results of the MARINA Study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:1868-1875.
6. Slakter JS, Bochow TW, D'Amico DJ, et al. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology 2006;113:3-13. (Pubitemid 43021721)
7. Moutray T, Alarbi M, Mahon G, et al. Relationships between clinicalmeasures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation. Br J Ophthalmol 2008;92:361-364. (Pubitemid 351363531)
8. Hangai M, Ojima Y, Yoshida A, et al. Improved visualization of foveal pathologies using Fourier-domain optical coherence tomography. Nippon Ganka Gakkai Zasshi 2007;111:509-517.
9. Hangai M, Ojima Y, Gotoh N, et al. Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 2007;114:763-773. (Pubitemid 46483687)
10. Chang LK, Koizumi H, Spaide RF. Disruption of the photoreceptor inner segment-outer segment junction in eyes with macular holes. Retina 2008;28:969-975.
11. Ota M, Tsujikawa A, Murakami T, et al. Association integrity of foveal photoreceptor layer and visual acuity in branched retinal vein occlusion. Br J Ophthalmol 2007;91:1644-1649. (Pubitemid 350207392)
12. Ota M, Tsujikawa A, Kita M, et al. Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina 2008;28:1502-1508.
13. Piccolino FC, de la Longrais RR, Ravera G, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005;139:87-99. (Pubitemid 40094844)
14. Eandi DM, Chung JE, Cardillo-Piccolino F, Spaide RF. Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 2005;25:417-421. (Pubitemid 40791877)
15. Otani T, Yamaguchi Y, Kishi S. Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 2010;30:774-780.
16. Wakabayashi T, Oshima Y, Fujimoto H, et al. Foveal microstructure and visual acuity after retinal detachment repair: Imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology 2009;116:519-528.
17. Hayashi H, Yamashiro K, Tsujikawa A, et al. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 2009;148:83-89.
18. Sayanagi K, Sharma S, Kaiser PK. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 2009;93: 622-626.
19. Oishi A, Hata M, Shimozono M, et al. The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmology 2010;150:27-32.
20. Marshall J, Hamilton AM, Bird AC. Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol 1975;59:610-630.
21. Zacks DN, Ezra E, Terada Y, et al. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: Angiographic and histologic characterization. Invest Ophthalmol Vis Sci 2002;43:2384-2391. (Pubitemid 34700672)
22. Reinke MH, Canakis C, Husain D, et al. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 1999; 106:1915-1923.
23. Postelmans L, Pasteels B, Coquelet P, et al. Severe pigment epithelial alternations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 2004;138:803-808. (Pubitemid 39452928)
24. Watchtlin J, Behme T, Heimann H, et al. Concentric retinal pigment epithelium atrophy after a single photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2003;241:218-221.
25. Yamaike N, Tsujikawa A, Ota M, et al. Three-dimensional imaging of cystoids macular edema in retinal vein occlusion. Ophthalmol 2008;115:355-362.
26. Sakamoto A, Tsujikawa A, Ota M, et al. Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion. Clin Experimental Ophthalmol 2009;37: 208-216.
27. Framme C, Panagakis G, Birngruber R. Effects on choroidal neovascularization after anti-VEGF upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography. Invest Ophthalmol Vis Sci 2010;51: 1671-1676.
28. Matsumoto H, Sato T, Kishi S. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol 2009;148: 105-110.
29. Vaclavik V, Vujosevic S, Dandekar SS, et al. Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: A prospective study. Ophthalmology 2008;115:342-346. (Pubitemid 351187793)
30. Klettner A, Roider J. Comparison of bevacizumab, renibizumab, and pegaptanib in vitro: Efficacy and possible additional pathway. Invest Ophthalmol Vis Sci 2008;49:4523-4527.
31. Chang T, Kokame G, Casey R, et al. Short-term effectiveness of intravitreal bevacizumab versus renibizumab injections for patients with neovascular age-related macular degeneration. Retina 2009;29:1235-1241.
32. Valmaggia C, Haueter I, Kloo P, et al. The treatment of choroidal neovascularizations in age-related macular degeneration using either Avastin or Lucentis. Klin Monbl Augenheilkd 2009;226:294-298.